Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Intravenous Anti-CGRP Therapy for the Treatment of Migraine
9
Mins
April 2025
This promotional advertorial article has been fully commissioned by Lundbeck Ltd. UK PI & AER info is available within the article…
Read more
14 Jul 2014
A Note on Changing Approach to Diagnosis of Alzheimer’s Disease
This short review summarises the conclusions of two different series of studies set out to revise the 1984 National Institute of Neurological and…
14 Jul 2014
Neuropsychiatric Features of Parkinson’s disease with Cognitive Impairment: An Overview
Parkinson’s disease (PD) is known to cause neuropsychiatric symptoms (NPS). It has been established that the more advanced the motor stage of PD is, the…
14 Jul 2014
Motor System Plasticity and Compensation in Multiple Sclerosis
Multiple sclerosis (MS) affects the central nervous system (CNS) by inflammatory lesions, direct axonal injury, and by a rather diffuse and widespread…
25 Nov 2013
Oligodendrogenesis After Cerebral Ischaemia and Traumatic Brain Injury
Stroke and traumatic brain injury (TBI) damage white and grey matter. Loss of oligodendrocytes and their myelin, impairs axonal function.
25 Nov 2013
Mode of Delivery in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearing age. Little is known about…
25 Nov 2013
Neurorehabilitation After Stroke
Recovery from ischaemic stroke is determined in the acute phase by the lesion impact of ischaemia and subsequently, by functional and structural network…
25 Nov 2013
Current Essentials in Inflammatory Myopathies
Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising…
Loading posts...
« Previous
1
…
18
19
20
We’ve noticed you’re accessing
from
North/South America.
View
View